Study identifier:NIS-CCO-ATA-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Economic Evaluation of Heart Failure management in Colombian clinics
heart failure, asthma
-
No
-
All
300
Observational
18 Years - 65 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2010 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.
No locations available
Arms | Assigned Interventions |
---|---|
1 moderate to severe uncontrolled asthma | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.